Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Novartis AG
Index- P/E24.26 EPS (ttm)3.79 Insider Own- Shs Outstand2.70B Perf Week3.04%
Market Cap248.10B Forward P/E16.06 EPS next Y5.72 Insider Trans- Shs Float412.76M Perf Month-1.36%
Income9.38B PEG2.51 EPS next Q1.29 Inst Own9.70% Short Float0.54% Perf Quarter5.81%
Sales56.90B P/S4.36 EPS this Y-2.40% Inst Trans-0.05% Short Ratio1.64 Perf Half Y5.25%
Book/sh28.89 P/B3.18 EPS next Y11.58% ROA7.80% Target Price98.69 Perf Year20.51%
Cash/sh2.72 P/C33.82 EPS next 5Y9.65% ROE13.60% 52W Range73.87 - 95.50 Perf YTD18.25%
Dividend2.72 P/FCF- EPS past 5Y0.80% ROI10.20% 52W High-3.72% Beta0.52
Dividend %2.96% Quick Ratio1.00 Sales past 5Y6.70% Gross Margin67.10% 52W Low24.48% ATR1.44
Employees135000 Current Ratio1.30 Sales Q/Q5.00% Oper. Margin20.80% RSI (14)56.77 Volatility1.21% 1.35%
OptionableYes Debt/Eq0.29 EPS Q/Q5.80% Profit Margin17.10% Rel Volume0.60 Prev Close91.31
ShortableYes LT Debt/Eq0.18 EarningsApr 19 Payout60.70% Avg Volume1.36M Price91.95
Recom2.20 SMA203.01% SMA500.74% SMA2005.98% Volume844,800 Change0.70%
16-Nov-09Initiated Deutsche Securities Buy
12-Nov-09Initiated Barclays Capital Underweight $48
30-Sep-09Upgrade Citigroup Hold → Buy
15-Sep-09Upgrade Jefferies & Co Hold → Buy
17-Jul-09Upgrade JP Morgan Neutral → Overweight
17-Mar-09Initiated Credit Suisse Neutral
27-Feb-09Reiterated Credit Suisse Neutral $14 → $7
26-Jan-09Initiated Jefferies & Co Hold
23-Sep-08Upgrade Credit Suisse Underperform → Neutral
06-Aug-08Downgrade JP Morgan Overweight → Neutral
12-Jun-08Downgrade HSBC Securities Neutral → Underweight $52 → $49
04-Jun-08Upgrade Cowen & Co Neutral → Outperform
09-May-08Upgrade Bernstein Mkt Perform → Outperform
08-Apr-08Downgrade Bear Stearns Outperform → Peer Perform
29-Feb-08Initiated Cowen & Co Neutral
29-Feb-08Downgrade HSBC Securities Neutral → Underweight
06-Sep-07Initiated UBS Buy
18-Jul-07Downgrade Credit Suisse Neutral → Underperform
01-Jun-07Reiterated Prudential Overweight $64 → $62
02-Apr-07Reiterated Banc of America Sec Buy $66 → $65
30-Oct-14 05:31PM  Veeva Systems Flies High On Cloud For Life Sciences at Investor's Business Daily
01:44PM  [video]Novartis, Taiwan Semi Tough to Beat Says Aberdeen Fund Manager at TheStreet
11:20AM  Did Novartis Make a Ham-Handed Move to Promote an Antibiotic for Pigs? at The Wall Street Journal
29-Oct-14 03:06PM  Pfizer meningitis vaccine wins U.S. approval Reuters
01:55PM  Novartis (NVS) Beats on Q3 Earnings, Revenues; Keeps View Zacks
28-Oct-14 06:46PM  Novartis Investor's Business Daily
03:34PM  NOVARTIS AG (NVS) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
01:04PM  Health Care Stocks On The Rise With Help From 3 Stocks at TheStreet
12:27PM  Novartis Q3 earnings boosted by new drugs at CNBC
07:34AM  Swiss drug maker Novartis posts strong profit AP
06:12AM  Novartis' precision M&A plan: CEO CNBC
06:11AM  Novartis CEO on big pharma pipeline CNBC
04:05AM  [$$] Novartis Up On Productivity Gains at The Wall Street Journal
02:13AM  Novartis Third-Quarter Profit Climbs on New Products at Bloomberg
27-Oct-14 01:38PM  Will Novartis (NVS) Disappoint in Q3 Earnings Season? Zacks
12:05PM  Novartis selling flu vaccine unit to CSL for $275M AP
10:11AM  [$$] CSL to Buy Novartis Influenza-Vaccine Unit for $275 Million at The Wall Street Journal
26-Oct-14 02:59PM  Drugmakers bet on Ebola vaccines, treatments at USA TODAY
24-Oct-14 08:55AM  Eli Lilly's Q3 Earnings In-Line but Generics Hit Revenues Zacks
08:35AM  Glaxo Gains on Q3 Earnings Beat and Restructuring Plans Zacks
08:21AM  High Drug Prices Could Increase Industry Innovation at Forbes
23-Oct-14 02:30PM  Novartis' Secukinumab Receives Favorable FDA Panel Vote Zacks
22-Oct-14 07:22AM  GSK revenue disappoints with 3% fall to $8.9B at CNBC
21-Oct-14 08:31AM  Cellular Immunotherapy & Unum Therapeutics: Out Of Many, One at Forbes
20-Oct-14 06:47PM  Can Valeant's Strong Q3 Entice Allergan? at Investor's Business Daily
06:21PM  European ETFs Plunge As Trouble Hits Region's Core at Investor's Business Daily
05:15PM  [$$] FDA Panel Calls for Psoriasis Drug Approval at The Wall Street Journal
16-Oct-14 05:40PM  Novartis Presents Encouraging Data on Leukemia Candidate Zacks
15-Oct-14 03:13PM  Why a single banking framework might help repair money in Europe Market Realist
02:53PM  Why Teva Pharmaceutical (TEVA) Stock Is Falling Today at TheStreet
14-Oct-14 05:15PM  Pfizer's Breast Cancer Candidate Gets Priority Review Zacks
13-Oct-14 04:57PM  Novartis Releases Data on Secukinumab for Plaque Psoriasis Zacks
10-Oct-14 03:45PM  Momenta Reveals Necuparanib Data for Pancreatic Cancer Zacks
04:34AM  Novartis strikes deal with Oxford BioMedica for cancer treatment at Financial Times
09-Oct-14 11:05AM  Must-See Charts: How to Trade 5 Big Stocks for Big Gains at TheStreet
07:30AM  Ebola an Issue for the Switzerland ETF ETF Trends
08-Oct-14 08:25AM  Shareholder group critical as Roche and Novartis chiefs top Swiss pay table Reuters
03:41AM  Novartis says 3 executives to leave after GSK, Lilly deals Reuters
07-Oct-14 03:50PM  Novartis Collaborates with Bristol-Myers Squibb Zacks
11:30AM  The Right ETFs for Europes Rising Dividends ETF Trends
06-Oct-14 08:35AM  Incyte Receives $60M Milestone Payment Related to Jakavi Zacks
03:17AM  Novartis works with Bristol-Myers Squibb to test lung cancer drugs Reuters
01:47AM  Novartis works with Bristol-Myers for lung cancer studies Reuters
05-Oct-14 10:31PM  '60 Minutes' Just Attacked High Drug Prices. Here's What You Should Know. at Forbes
03-Oct-14 06:41AM  EU OKs Eli Lilly's $5.4B bid for Novartis division AP
02-Oct-14 11:25AM  Novartis (NVS) Presents Data on Zykadia and Afinitor Zacks
08:55AM  Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst at 24/7 Wall St.
30-Sep-14 01:24PM  Novartis ordered to face U.S. lawsuit over doctor kickbacks Reuters
29-Sep-14 03:35PM  Novartis Gives Updates on Signifor LAR and Secukinumab Zacks
26-Sep-14 06:07PM  Multiple Sclerosis Drugs Could Transform Market Again at Investor's Business Daily
25-Sep-14 08:16AM  Ford revs up expansion plans CNBC
02:31AM  Novartis Says Psoriasis Drug Met End-Goal of Arthritis Studies at Bloomberg
23-Sep-14 10:04AM  Could European Funds Offer An Opportunity Now? Benzinga
22-Sep-14 03:45PM  Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published Zacks
02:11PM  [video] Prologis, Wells Fargo Still Wise Investments Says Fund Manager at TheStreet
18-Sep-14 12:54PM  IPO Stock Watch: Biotech ProQR Rises In IPO Debut at Investor's Business Daily
17-Sep-14 05:12PM  The Market's Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
16-Sep-14 05:10PM  Roche Starts Trials on Lampalizumab for Geographic Atrophy Zacks
06:35AM  Ebola under the microscope CNBC
06:35AM  [video] Ebola under the microscope at CNBC
15-Sep-14 04:35PM  Novartis Presents Positive Data on Lucentis and Jetrea Zacks
14-Sep-14 04:34PM  3 Companies Investing In Stem Cell Research Benzinga
11-Sep-14 04:55PM  Novartis Presents Data on Multiple Sclerosis Drug Gilenya Zacks
10-Sep-14 11:58AM  ReceptosMS Drug Yields More Good Data; Stock Jumps at Investor's Business Daily
08-Sep-14 04:05PM  Novartis (NVS) Presents Positive Data on Ultibro Breezhaler Zacks
05-Sep-14 07:00AM  Blockbusters Differentiate Novartis Morningstar
06:30AM  Novartis Offers Healthy Gains at a Bargain Stock Price at TheStreet
04-Sep-14 01:00PM  Why are Irelands labor markets more flexible than Spains? Market Realist
03-Sep-14 05:41PM  The Market's Roses, Thorns, and All Time Highs... Yahoo Finance Blogs
02-Sep-14 06:35PM  2014 Jackson Hole Symposium revaluates labor market dynamics Market Realist
06:04PM  Novartis, Regeneron Shares Advance To New Highs On Updated Drug News Investor's Business Daily
05:39PM  Today's Thorns, Roses and All Time Highs in the Markets... Yahoo Finance Blogs
05:25PM  United Therapeutics Soars on Remodulin Patent Case Win Zacks
04:10PM  Novartis Releases Positive Data on LCZ696 for Heart Failure Zacks
04:02PM  [$$] Blockbuster Expectations for Novartis' Heart Drug at Barrons.com
11:19AM  Novartis, Regeneron Hit New Highs On Cardio Drugs at Investor's Business Daily
10:19AM  Why Novartis AG (NVS) Stock Is Climbing Today at TheStreet
08:17AM  Novartis' Game Changer: When Failure Turns To Success at Forbes
01-Sep-14 11:08AM  Heart Drug Study Gives Novartis a Shot in the Arm at The Wall Street Journal
03:27AM  Novartis Rises Most in Five Months on Heart-Drug Trial at Bloomberg
31-Aug-14 12:37PM  Heart drug launch could be "most exciting ever", says Novartis Reuters
30-Aug-14 12:21PM  Novartis' investigational heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in PARADIGM-HF trial CNW Group
11:42AM  Study: Novel heart failure drug shows big promise at USA TODAY
07:38AM  [$$] Novartis Data Show Heart Drug Beats Rival at The Wall Street Journal
07:03AM  Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial PR Newswire
07:00AM  New Novartis Drug Effective in Treating Heart Failure at New York Times
07:00AM  Novartis Heart Failure Drug Tops Standard in Study at Bloomberg
27-Aug-14 10:00AM  Predicting PARADIGM-HF, Or What To Expect When You're Expecting at Forbes
25-Aug-14 05:50PM  [video] A sensor to swallow with your medicine at CNBC
20-Aug-14 05:13PM  Novartis to Invest $35M in Gamida Cell for 15% Equity Zacks
19-Aug-14 08:28AM  Why Novartis (NVS) Stock Is Gaining Today at TheStreet
05:33AM  Novartis to invest in Israel's Gamida Cell, could buy out company Reuters
15-Aug-14 10:13AM  Digital Transformation Moves Pharma 'Beyond the Pill' at Forbes
14-Aug-14 08:33PM  [video] Eyeball injections equal eye-popping profits at CNNMoney.com
13-Aug-14 11:31AM  Cancer: Unpronounceable Drugs, Incomprehensible Prices at Forbes
08-Aug-14 08:18AM  Even At $900 (Vs. $84,000 In US) Hep C Cure Sovaldi's Cost Could Be Unacceptable In India at Forbes
07-Aug-14 08:27PM  Novartis loses new bid to dismiss U.S. lawsuit over kickbacks Reuters
06-Aug-14 09:50AM  QLT Q2 Loss Widens, Focus on Impending Merger with Auxilium Zacks
01-Aug-14 08:47AM  GlaxoSmithKline LLC -- Moody's downgrades GlaxoSmithKline to A2, outlook stable at Moody's
30-Jul-14 05:00PM  Novartis Malaria Pill Shows Promise as Best Drugs Fail at Bloomberg
Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism. The company's Alcon division provides various eye care products, including ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; cytotoxic products for the hospital market; and biotech manufacturing services to other companies. The company's Vaccines and Diagnostics division provides preventive human vaccines. Its Consumer Health division offers over-the-counter medicines comprising readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. The company distributes its OTC products through various channels, such as food, drug, and mass retail outlets, as well as pharmacies; and Animal Health products directly and through wholesalers of veterinary products. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novartis Bioventures Ltd10% OwnerSep 22Buy15.00325,0004,875,0004,644,328Sep 24 05:42 PM